Artificial intelligence virtual patients

Translating fine-grained intracellular dynamics into predictable systemic clinical phenotypes remains a core challenge in biomedical research. This review explores the architectural continuum and translational value of artificial intelligence (AI) virtual patients (AIVPs) for bridging the gap between microscale biological mechanisms and macroscale clinical manifestations. We clarify the computational hierarchy of AIVPs, covering AI-based virtual cells, AI-based virtual extracellular vesicles, and AI virtual organoids. These modules jointly form the mechanistic basis of the integrated AIVP models. This review also clearly distinguishes between the epistemological connotations of AIVPs and digital twins (DTs). AIVPs act as population-level synthetic archetypes optimized for in silico clinical trials, whereas DTs serve as individualized longitudinal replicas updated by real-world data assimilation. Focusing on pharmaceutical research and development and regulatory science, we discuss the capacity of AIVP cohorts to reduce developmental risks in drug research. These in silico models can be used to construct synthetic control arms, optimize dynamic precision dosing, and accelerate regulatory progress via Model-Informed Drug Development. We further summarize the key obstacles restricting the clinical translation of AIVPs, including epistemological limitations, inadequate infrastructure, and complex socio-regulatory constraints. Resolving data fragmentation, reducing algorithmic bias, and unifying verification and validation standards are critical for transforming AIVPs from theoretical prototypes into credible regulatory and clinical tools (Graphical Abstract).

Authors

Institutions

Publication Details

Journal
EngMedicine
Published
2026-11-13
DOI
https://doi.org/10.1016/j.engmed.2026.100171
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial intelligence virtual patients

Yinglong Zhang, 梁远乔, Wei Guo, Yanhong Pei et al.
1 links
EngMedicine
Artificial Intelligence in Healthcare and Education
article

Artificial intelligence virtual patients

Yinglong Zhang, 梁远乔, Wei Guo, Yanhong Pei, Xiaoya Li, Zhenyue Zhang, Zhongyang Liu, Ping Song, Aiyuan Wang, Xin Yin
article en

Abstract

Translating fine-grained intracellular dynamics into predictable systemic clinical phenotypes remains a core challenge in biomedical research. This review explores the architectural continuum and translational value of artificial intelligence (AI) virtual patients (AIVPs) for bridging the gap between microscale biological mechanisms and macroscale clinical manifestations. We clarify the computational hierarchy of AIVPs, covering AI-based virtual cells, AI-based virtual extracellular vesicles, and AI virtual organoids. These modules jointly form the mechanistic basis of the integrated AIVP models. This review also clearly distinguishes between the epistemological connotations of AIVPs and digital twins (DTs). AIVPs act as population-level synthetic archetypes optimized for in silico clinical trials, whereas DTs serve as individualized longitudinal replicas updated by real-world data assimilation. Focusing on pharmaceutical research and development and regulatory science, we discuss the capacity of AIVP cohorts to reduce developmental risks in drug research. These in silico models can be used to construct synthetic control arms, optimize dynamic precision dosing, and accelerate regulatory progress via Model-Informed Drug Development. We further summarize the key obstacles restricting the clinical translation of AIVPs, including epistemological limitations, inadequate infrastructure, and complex socio-regulatory constraints. Resolving data fragmentation, reducing algorithmic bias, and unifying verification and validation standards are critical for transforming AIVPs from theoretical prototypes into credible regulatory and clinical tools (Graphical Abstract).

EngMedicineVol. 4(1)
Peking University (CN), Chinese PLA General Hospital (CN), Peking University People's Hospital (CN)
National Natural Science Foundation of China, General Hospital of People’s Liberation Army, Beijing Nova Program
Good health and well-being
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon